Eight Professors Appointed Penn Fellows
The Penn Fellows program, begun in 2009, provides leadership development to select Penn faculty members in mid-career. It includes opportunities to build cross-campus alliances, meet distinguished academic leaders, think strategically about universities and university governance, and consult with Penn’s senior administrators.
The 2014 Penn Fellows are:
Paulo Arratia, Associate Professor of Mechanical Engineering and Applied Mechanics in the School of Engineering and Applied Science, studies the flow behavior of complex fluids, such as human blood, polymeric solutions, and colloidal suspensions.
Jennifer Blouin, Associate Professor of Accounting in the Wharton School, studies taxation, including the effects of taxes on asset pricing, capital structure, corporate payout policies, and multinational firm behavior.
Sara Cherry, Associate Professor of Microbiology in the Perelman School of Medicine, studies the cellular factors that regulate viral pathogenesis, especially in such mosquito-borne viruses as West Nile virus and Rift Valley Fever virus.
Justin Khoury, Associate Professor of Physics in the School of Arts and Sciences, works at the intersection of particle physics and cosmology, especially alternative theories of the early universe designed to address traditional problems of “big bang” cosmology.
Emilio Parrado, Professor of Sociology in the School of Arts and Sciences, studies migration, both within and across countries, including immigrant adaptation, international migration, and social and demographic change in Latin America.
Laura Perna, Professor in the Higher Education Division of the Graduate School of Education, studies the forces that may limit and the ways to promote educational attainment, especially among members of historically underrepresented groups.
Adriana Petryna, Edmund J. and Louise W. Kahn Term Professor of Anthropology in the School of Arts and Sciences, studies the social and political dimensions of science and medicine in the United States and Eastern Europe.
Ronald Rubenstein, Associate Professor of Pediatrics in the Perelman School of Medicine, studies novel drug therapies for cystic fibrosis, especially the use of pharmaceuticals to overcome molecular defects and “repair” dysfunctional proteins.